Ariad Pharmaceuticals (NASDAQ:ARIA Director Sarah J. Schlesinger bought 5,200 shares of Ariad Pharmaceuticals stock on the open market in a transaction that occurred on Wednesday, September 10th. The shares were purchased at an average cost of $5.73 per share, with a total value of $29,796.00. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is -3.27%. On last trading day company shares ended up $5.62. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) distance from 50-day simple moving average (SMA50) is -3.48%.

On Sep 19, VIVUS Inc. (NASDAQ:VVUS) and Auxilium Pharmaceuticals, Inc. ( AUXL ) announced that the FDA has approved their erectile dysfunction (ED) drug, Stendra’s (EU trade name: Spedra) supplemental new drug application (sNDA) to include 15 minutes onset of action. VIVUS Inc. (NASDAQ:VVUS) shares moved up 2.16% in last trading session and ended the day at $4.25. VVUS Gross Margin is 84.20% and its return on assets is -25.50%. VIVUS Inc. (NASDAQ:VVUS) quarterly performance is -19.81%.

Miller Energy Resources (NASDAQ:MILL) CEO Carl Fredrick Giesler acquired 20,000 shares of the company’s stock on the open market in a transaction dated Friday, September 19th. The shares were purchased at an average price of $4.89 per share, for a total transaction of $97,800.00. Following the completion of the transaction, the chief executive officer now directly owns 660,000 shares in the company, valued at approximately $3,227,400. On 22 September, Miller Energy Resources, Inc. (NYSE:MILL) shares decreased -4.73% and was closed at $4.63. MILL EPS growth in last 5 year was -29.80%. Miller Energy Resources, Inc. (NYSE:MILL) year to date (YTD) performance is -34.23%.

RCS Capital Corp (NASDAQ:RCAP) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research note issued on Wednesday. They currently have a $25.30 price objective on the stock . Zacks‘s price objective would suggest a potential upside of 3.65% from the company’s current price. RCS Capital Corporation (NYSE:RCAP) ended the last trading day at $23.34. Company weekly volatility is calculated as 3.70% and price to cash ratio as 3.39. RCS Capital Corporation (NYSE:RCAP) showed a weekly performance of -2.75%.

Fred’s, Inc. (NASDAQ:FRED) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C. Fred’s, Inc. (NASDAQ:FRED) shares decreased -1.30% in last trading session and ended the day at $14.42. FRED Gross Margin is 27.20% and its return on assets is 0.10%. Fred’s, Inc. (NASDAQ:FRED) quarterly performance is -3.55%.